SMTL ID : 8djc.1 (1 other biounit)

CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH (4S)-N-{4-[(2S)-2-methylmorpholin-4-yl] pyridin-3-yl}-2-phenylimidazo[1,2-b]pyridazine-8-carboxamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.46 Å

Oligo State

monomer

Ligands

1 x UAU: (4S)-N-{4-[(2S)-2-methylmorpholin-4-yl]pyridin-3-yl}-2-phenylimidazo[1,2-b]pyridazine-8-carboxamide(Non-covalent)

UAU.1: 20 residues within 4Å: Chain A: I.83, G.84, F.88, V.91, A.104, K.106, V.131, L.153, D.154, Y.155, V.156, P.157, E.158, T.159, R.162, Q.206, N.207, L.209, C.220, D.221 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.83, A:I.83, A:F.88, A:A.104, A:V.131, A:L.209 Hydrogen bonds: A:V.156 Water bridges: A:D.221

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hartz, R.A. et al., Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2- b ]pyridazines as Glycogen Synthase Kinase-3 beta (GSK-3 beta ) Inhibitors. J.Med.Chem. (2023)

Release Date

2023-03-22

Peptides

Glycogen synthase kinase-3 beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Glycogen synthase kinase-3 beta

Related Entries With Identical Sequence